Results 91 to 100 of about 12,682 (143)

Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue. [PDF]

Sci Rep
Moldovan I, Fechete R, Bîrla A, Orban E, Sipos RS.   +4 more
europepmc   +1 more source

Diabetes and the Retina: The Role of Medical Treatment. [PDF]

J Diabetes
Bloomgarden Z.
europepmc   +1 more source

Fenofibrate alleviates sepsis-associated acute kidney injury by enhancing renal fatty acid oxidation. [PDF]

BMC Pharmacol Toxicol
Zeng S, Wang J, Guan C, Yao Z, Zhang Y, Li Y, Zheng J, Wang H.   +7 more
europepmc   +1 more source

Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice. [PDF]

Chin Med
Zhang Z, Tang EQ, Li CH, Wang BB, Liang Y, Lv JX, Chen GF, Liu W, Mu YP, Liu P, Chen JM.   +10 more
europepmc   +1 more source

Rapid Glycemic Correction and the Paradox of Retinopathy Progression. [PDF]

Endocrinol Metab (Seoul)
Choe HJ, Hong EG.
europepmc   +1 more source

Oral therapies for diabetic retinopathy: Addressing an unmet need or a distant prospect? [PDF]

J Int Med Res
Empeslidis T, Panos GD, Balaskas K, Almeida DR.   +3 more
europepmc   +1 more source

Fenofibrate as a PPARα Agonist Modulates Neuroinflammation and Glutamate Receptors in a Rat Model of Temporal Lobe Epilepsy: Region-Specific Effects and Behavioral Outcomes. [PDF]

Int J Mol Sci
Kovalenko AA, Zakharova MV, Zubareva OE, Schwarz AP, Skorik YA, Zaitsev AV.   +5 more
europepmc   +1 more source

Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases. [PDF]

Front Pharmacol
Watanabe S, Nagura K, Okada N, Watanabe T, Sagara H.   +4 more
europepmc   +1 more source

Different aspects of pharmacological heart failure treatment. [PDF]

Eur Heart J Cardiovasc Pharmacother
Agewall S.
europepmc   +1 more source

TAS1R3 influences GTPase-dependent signaling in human islet β-cells. [PDF]

Front Endocrinol (Lausanne)
Veluthakal R, Ahn M, Oh E, Thurmond DC.
europepmc   +1 more source